• Wed news: 2025 Medicare drug price negotiations. BioAge Labs aiming at $180M IPO. Merck Keytruda colorectal cancer flop. Sanofi gets bids for consumer health unit. Novo Nordisk CEO in Senate hot seat. See more on our front page

ValGan Happening ... Here's Why

Anonymous

Guest
Bloomberg is reporting that JNJ & SNY have rejected to be AGN white knight

VRX has formally started process for gathering AGN shareholders contact information for special meeting

AGN is preparing to reject VRX offer and VRX is preparing to offer more cash and increase the offer from 152 to 178. VRX will up the ante extremely fast as soon as AGN makes a move

AGN management is acting exactly like B&L management i.e. creating facade of normality, providing no information, acting as if VRX will drop the bid

To AGN people, be prepared to be surprised one morning with the dreaded announcement in next couple of weeks
 

<